Drug · DIN 02420686
FLUVIRAL
TRIVALENT, SPLIT-VIRION, INACTIVATED INFLUENZA VACCINE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since September 8, 2025; first marketed September 23, 2015.
- Drug Identification Number (DIN)
- 02420686
- Company (DIN owner)
- Id Biomedical Corporation Of QuebecQuebec, Quebec, Canada
- Schedule
- Schedule d
- Dosage form
- Suspension
- Route
- Intramuscular
- Therapeutic class (ATC)
- Influenza, inactivated, split virus or surface antigen J07BB02
- Class
- Human
- Record last updated
- September 4, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| HAEMAGGLUTININ-STRAIN A (H1N1) | 15 MCG | 0.5 ML |
| HAEMAGGLUTININ-STRAIN A (H3N2) | 15 MCG | 0.5 ML |
| HAEMAGGLUTININ-STRAIN B | 15 MCG | 0.5 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 6, 2014: NOC 15202New Drug Submission (NDS)
Other DINs named FLUVIRAL
- DIN 01914510 · Cancelled Post Market
- DIN 02015986 · Cancelled Post Market
- DIN 02567695 · Approved